Primary haemostasis: Newer insights
MetadataShow full item record
At the same time as biophysical and omics approaches are drilling deeper into the molecular details of platelets and other blood cells, as well as their receptors and mechanisms of regulation, there is also an increasing awareness of the functional overlap between human vascular systems. Together, these studies are redefining the intricate networks linking haemostasis and thrombosis with inflammation, infectious disease, cancer/metastasis and other vascular pathophysiology. The focus of this state-of-the-art review is some of the newer advances relevant to primary haemostasis. Of particular interest, platelet-specific primary adhesion-signalling receptors and associated activation pathways control platelet function in flowing blood and provide molecular links to other systems. Platelet glycoprotein (GP)Iba of the GPIb-IX-V complex and GPVI not only initiate platelet aggregation and thrombus formation by primary interactions with von Willebrand factor and collagen, respectively, but are also involved in coagulation, leucocyte engagement, bacterial or viral interactions, and are relevant as potential risk markers in a range of human diseases. Understanding these systems in unprecedented detail promises significant advances in evaluation of individual risk, in new diagnostic or therapeutic possibilities and in monitoring the response to drugs or other treatment. © 2014 John Wiley & Sons Ltd.
Showing items related by title, author, creator and subject.
Metharom, P.; Berndt, Michael; Baker, R.; Andrews, R. (2015)An unresolved problem with clinical use of antiplatelet therapy is that a significant number of individuals either still get thrombosis or run the risk of life-threatening bleeding. Antiplatelet drugs are widely used ...
Qiao, J.; Wu, Yong Hong; Wu, X.; Liu, Y.; Li, X.; Ju, W.; Qi, K.; Li, D.; Gardiner, E.; Andrews, R.; Zeng, L.; Xu, K. (2017)Increased risk of thromboembolism and platelet hyperreactivity has been reported in patients receiving thalidomide therapy. Whether thalidomide induces platelet activation directly or through other factors remains unclear. ...
Specific inhibition of ectodomain shedding of glycoprotein lba by targeting its juxtamembrane shedding cleavage siteLiang, X; Russell, S; Estelle, S; Jones, L; Cho, S; Khan, M; Berndt, Michael; Bunting, S; Ware, J; Li, R (2013)Background: Ectodomain shedding of glycoprotein Ibα (GPIbα), a proteolytic event in which metalloprotease ADAM17 cleaves the Gly464-Val465 bond and releases glycocalicin to the plasma, is considered a critical step in ...